Associated Papers
Loss of p53 and SMAD4 induces adenosquamous subtype pancreatic cancer in the absence of an oncogenic KRAS mutation.
Yang D et al.
Cell Reports. Medicine, 2024
Myc upregulates Ggct, γ-glutamylcyclotransferase to promote development of p53-deficient osteosarcoma.
Ueno T et al.
Cancer Science, 2024
RAS mutations in myeloid malignancies: revisiting old questions with novel insights and therapeutic perspectives.
Alawieh D et al.
Blood Cancer Journal, 2024
Genetic ablation of ketohexokinase C isoform impairs pancreatic cancer development.
Guccini I et al.
Iscience, 2023
Driver Mutations of Pancreatic Cancer Affect Ca2+ Signaling and ATP Production.
Stopa KB et al.
Function (oxford, England), 2023
Immunosuppression and outcomes in adult patients with de novo acute myeloid leukemia with normal karyotypes.
Ferraro F et al.
Proceedings of the National Academy of Sciences of the United States of America, 2021
34845035 (PubMed )
Supplement: pnas.2116427118.sd02.xlsx › mutations.2021.02.24
Transposon mutagenesis identifies cooperating genetic drivers during keratinocyte transformation and cutaneous squamous cell carcinoma progression.
Aiderus A et al.
Plos Genetics, 2021
Genomic characterization of Chinese ovarian clear cell carcinoma identifies driver genes by whole exome sequencing.
Yang Q et al.
Neoplasia (new York, N.y.), 2020
BRAFV600E drives dedifferentiation in small intestinal and colonic organoids and cooperates with mutant p53 and Apc loss in transformation.
Reischmann N et al.
Oncogene, 2020
Targeting the Oncogenic p53 Mutants in Colorectal Cancer and Other Solid Tumors.
Li H et al.
International Journal of Molecular Sciences, 2019
Analyzing tumor heterogeneity and driver genes in single myeloid leukemia cells with SBCapSeq.
Mann KM et al.
Nature Biotechnology, 2016
Select a paper to view details